top of page

Psychological Encyclopedia

Stigma and Schizophrenia: Myths, Discrimination, and Recovery

7 days ago
18 min read

Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy


Schizophrenia stigma consists of stereotypes, prejudice, social exclusion, discriminatory behavior, and institutional barriers directed at people diagnosed with schizophrenia or perceived as having it. It can affect employment, health care, housing, education, relationships, and willingness to seek support. The diagnosis describes a clinical condition; it does not establish a person's character, potential, safety, intelligence, or value. Reducing stigma requires accurate knowledge, respectful relationships, practical access to care, and action against discrimination. World Health Organization


Many misconceptions begin with confusion between schizophrenia and psychosis. Psychosis is a clinical syndrome or symptom presentation involving possible hallucinations, delusions, or disorganized thinking, and it occurs in several psychiatric, neurological, substance-related, and medical conditions. Schizophrenia is one clinical disorder for which a qualified professional must assess the pattern, duration, functional effects, and competing explanations. A single unusual experience, screening response, or diagnostic label used by a bystander cannot establish schizophrenia. National Institute of Mental Health


The most useful approach to schizophrenia stigma combines two ideas: people deserve equal rights and social belonging, and people who need clinical treatment deserve effective, individualized care. Both principles are central to the Lancet Commission on ending stigma and discrimination and the WHO schizophrenia fact sheet, updated September 11, 2026.


What Is Schizophrenia Stigma?


Stigma is a social process through which a characteristic becomes associated with devaluing judgments and unequal treatment. Schizophrenia-related stigma may arise after someone discloses a diagnosis, when others interpret a person's behavior through stereotypes, or when public institutions make decisions based on generalized assumptions. It can also affect someone who has experienced psychosis but has never been diagnosed with schizophrenia.


Public stigma involves negative attitudes held by other people: fear, social distance, ridicule, pity that undermines autonomy, or beliefs that someone is inherently unreliable. Interpersonal discrimination occurs when those attitudes turn into concrete actions, such as exclusion from a friendship, rejection for a position despite adequate qualifications, or dismissive treatment by a professional.


Structural stigma describes barriers embedded in rules, institutional practices, funding decisions, and service systems. A person may face poor coordination between psychiatric and physical health care, restricted access to stable housing, inaccessible services, or the assumption that meaningful work and education are unrealistic. Structural discrimination can persist even when individual workers consider themselves sympathetic. WHO and OHCHR human-rights guidance


Anticipated stigma means expecting rejection, even before it occurs. This expectation can be grounded in prior discrimination, media messages, or observations of how other people are treated. It may influence whether a person tells friends, applies for work, dates, or asks for assistance. Experienced stigma refers to events that actually occur; perceived stigma refers to a person's understanding of the judgments and rejection around them. These concepts overlap, but research instruments do not always measure them in the same way.


Internalized stigma, also called self-stigma, develops when someone begins to apply negative social stereotypes to themselves. It can appear as shame, reduced confidence, isolation, or the belief that future goals are automatically closed. Internalized stigma is neither a defining symptom of schizophrenia nor proof of weak character. It is one potentially modifiable response to a stigmatizing environment. A systematic review and meta-analysis of 37 studies across 25 countries found substantial variation in dimensions of self-stigma and associated social circumstances.


Ten Common Schizophrenia Myths and What the Evidence Shows


Myth 1: Schizophrenia means having multiple personalities


Schizophrenia and dissociative identity disorder are different clinical diagnoses. The phrase split personality is misleading when used as a synonym for schizophrenia. Schizophrenia can involve hallucinations, delusions, disorganized speech, reduced motivation, and cognitive difficulties, while dissociative identity disorder involves distinct identity states and discontinuities in memory and sense of self. Neither disorder can be identified from a movie character or an isolated anecdote. The NIMH schizophrenia guidance specifically addresses this confusion.


Myth 2: Everyone with schizophrenia is dangerous


Most people living with schizophrenia are not violent. Population-level research on violence risk concerns statistical associations and contextual factors; it cannot be used to judge whether a particular individual poses a threat. Violence risks are influenced by multiple variables, including untreated acute symptoms in some circumstances, substance use, previous violence, and social adversity. People with schizophrenia can also be vulnerable to victimization and exploitation. NIMH emphasizes both that most people with schizophrenia are not violent and that they are more likely than other people to be harmed by others.


Responsible safety assessment examines actual behavior, immediate threats, current circumstances, and access to care. It never substitutes diagnosis alone for evidence of dangerousness. Media coverage that repeatedly associates psychosis with unpredictable violence makes this distinction harder for the public to retain. Questions about violence patterns belong to research and appropriate clinical or forensic assessment, not casual labeling.


Myth 3: Someone with schizophrenia can never recover


Recovery is a meaningful and evidence-supported possibility. It can include reduced symptoms, improved functioning, stable relationships, valued daily activities, and a self-directed life. Clinical remission, functional recovery, and personal recovery describe related but different outcomes. Progress may be gradual and nonlinear, and some people require substantial long-term assistance. The WHO states that at least one in three people with schizophrenia can fully recover, while the NIMH RAISE initiative demonstrates the benefits of coordinated early care.


A population statistic cannot predict an individual's future. Recovery is also wider than an all-or-nothing symptom threshold: education, work, friendships, health, housing, and dignity can improve even when some symptoms continue. For a detailed examination of remission and long-term outcomes, read Can You Recover From Schizophrenia? Outcomes and Long-Term Care.


Myth 4: People with schizophrenia cannot work, study, or learn


Symptoms, medication effects, discrimination, and interruptions in schooling or employment can affect opportunities, and support needs differ greatly. Yet many people pursue education, work, creative projects, caregiving, and community roles. The false assumption that everyone is permanently incapable can itself become a barrier to hiring and access to training.


Supported employment, including Individual Placement and Support, helps people who want competitive jobs engage in an individualized employment pathway. A research review of Individual Placement and Support summarizes consistent evidence that it improves competitive employment outcomes for people with serious mental illness in high-income settings. The findings apply to the service model and relevant study groups, not to a claim that every participant will obtain or keep the same job.


Myth 5: Schizophrenia is caused by bad parenting or weak willpower


Schizophrenia is a multifactorial psychiatric disorder. Research investigates genetic vulnerability, neurodevelopment, brain processes, environmental exposures, and other interacting factors. Blaming parents, family members, or the person experiencing symptoms substitutes moral accusation for clinical understanding. Families vary widely, and conflict or caregiving stress should be addressed without assigning simplistic causal guilt. NIMH and WHO summarize the multifactorial evidence.


Myth 6: A hallucination automatically means schizophrenia


Hallucinations can arise in several clinical and nonclinical contexts, and a report of hearing or seeing something unusual requires attention to context, distress, persistence, functioning, substances, medication effects, sleep, and medical symptoms. Psychosis can occur with mood disorders, delirium, neurological illnesses, substance-related states, and other conditions. A positive screening response is information for a clinical assessment; it is not a confirmed diagnosis. NIMH Understanding Psychosis explains this broader differential.


Myth 7: People with schizophrenia have no insight, agency, or decision-making capacity


Insight into an illness can change over time and differs between individuals. Clinical decision-making capacity concerns a particular decision at a particular time; it cannot be inferred from a diagnostic label alone. People should receive accessible explanations, opportunities to express preferences, and support for informed decisions. Supportive involvement from family or advocates should follow the person's wishes and applicable privacy and capacity law. WHO and OHCHR guidance emphasizes human rights and supported decision-making.


Myth 8: Medication is the only useful form of care


Antipsychotic medications are important evidence-based treatments for schizophrenia, prescribed and monitored through clinical care. Effective services can also include cognitive behavioral therapy for psychosis, family education, supported employment, physical health monitoring, peer support, and practical assistance. Treatment choices involve benefits, side effects, prior response, access, and individual preferences. NICE CG178 recommends coordinated psychological, pharmacological, social, and occupational interventions. Decisions to start, adjust, or discontinue prescribed medication should be made with an appropriate clinician.


Myth 9: People living with schizophrenia cannot have close relationships


People with schizophrenia have the same range of needs for friendship, intimacy, family, belonging, and emotional security as other people. The practical realities of symptoms, stigma, socioeconomic conditions, and treatment can affect relationships, and some people choose to be more private or prefer smaller social networks. There is no diagnostic rule that eliminates the possibility of reciprocal care, affection, partnership, or parenting. Family interventions and shared planning can improve support while preserving boundaries and autonomy. NICE CG178.


Myth 10: A diagnosis tells you everything about the person


Schizophrenia is a clinical descriptor and one part of a person's medical history. It does not reveal their intelligence, personality, moral responsibility, culture, ambitions, humor, skills, or preferred identity. Two people with the same diagnosis may have markedly different strengths and needs. A respectful response asks what support, accommodation, or information is relevant, rather than constructing an entire life from a label.


How Stigma and Discrimination Affect Everyday Life


Employment and education


Stigma can shape hiring decisions, workplace trust, promotion, educational expectations, and access to accommodations. Some people encounter overt rejection after disclosure; others experience subtle exclusion or reduced responsibility. Repeated discouragement can undermine confidence and opportunities, especially when work experience is already interrupted by illness or hospitalization.


Employers and educators should focus on role requirements, demonstrated ability, relevant adjustments, and individual circumstances. Flexible scheduling, predictable communication, reduced unnecessary sensory overload, supported transition back after leave, and coordination with chosen support services may help some people. Workplace adjustments should be selected collaboratively rather than imposed because of a diagnosis. The NICE guideline supports access to employment and education, and IPS evidence supports individualized employment services.


Housing, income, and community inclusion


Stable housing and financial security influence access to treatment, routines, relationships, and participation. Landlord stereotypes, poverty, fragmented benefits systems, and service shortages can contribute to exclusion. Stigma may also appear in public spaces when behavior is misinterpreted or someone is viewed as unworthy of ordinary customer, neighbor, or community-member status. Public policy must therefore address practical resources alongside public attitudes. The WHO human rights guidance identifies community inclusion, quality care, and protection from discrimination as core obligations.


Health care and diagnostic overshadowing


In health care, diagnostic overshadowing occurs when physical symptoms or other concerns are minimized because a psychiatric diagnosis is already known. A person who has schizophrenia still needs comprehensive evaluation of pain, infection, cardiovascular risks, medication adverse effects, neurological changes, and other problems. Symptoms should be assessed on their own merits, with appropriate clinical differential diagnosis.


A 2025 systematic review of 44 studies documented schizophrenia-spectrum stigma among health professionals and trainees, underscoring that professional training alone does not automatically eliminate stereotypes. The right response includes equitable physical health screening, accessible communication, meaningful consent processes, and escalation when a medical complaint is being dismissed.


Friendships, family, and intimate relationships


Stigma may reduce invitations, erode trust, or pressure people to conceal experiences. Family members can experience associative stigma, sometimes called courtesy stigma, when other people judge them for being related to a person with a diagnosis. A family can also become unintentionally stigmatizing by interpreting every disagreement as a symptom or assuming the person cannot make ordinary choices.


Families and friends can improve relationships by listening, learning how symptoms affect the individual, agreeing on helpful responses during difficult periods, and protecting ordinary conversation from becoming entirely illness-focused. NICE recommends family education and family interventions as part of condition-specific care.


Help-seeking, treatment, and quality of life


Fear of being judged can discourage people from describing emerging difficulties or returning to treatment after a disappointing experience. Internalized stigma may increase withdrawal, while structural barriers can delay access regardless of motivation. These influences can coexist with hallucinations, negative symptoms, cognitive challenges, depression, and practical obstacles. Stigma should therefore be evaluated as one determinant of care engagement, never used as the sole explanation for a person's choices.


In a 2022 meta-analysis, self-stigma was examined alongside psychosocial and clinical variables across cultures. The findings support taking self-stigma seriously, while observed associations do not demonstrate a single causal pathway for every person.


Self-Stigma: When Public Stereotypes Become Personal Beliefs


Self-stigma may look like rejecting an opportunity before applying, believing that a relationship is impossible, hiding from valued communities, or interpreting every setback as evidence of permanent incapacity. It can coexist with real discrimination. Addressing internalized beliefs should never become a demand that individuals ignore unfair treatment or carry sole responsibility for fixing a discriminatory environment.


For someone struggling with shame, a useful starting point is to separate a clinical description from a global judgment about the self. What happened? Which conclusion about identity followed? Is the conclusion supported by the person's actual abilities, aspirations, and circumstances? Which social barrier is external and needs accommodation or advocacy? These questions can form part of reflective work with a clinician or trusted supporter.


Interventions to reduce self-stigma have a developing evidence base. A 2024 systematic review and meta-analysis found that multicomponent programs combining psychoeducation, cognitive approaches, and social skills elements appeared more effective than simpler approaches in the included psychosis studies. Effects and program quality vary, and these interventions complement rather than replace indicated schizophrenia treatment or anti-discrimination policies.


Peer connection may counter isolation by providing opportunities to learn from people with lived experience who have different recovery paths. Peer support is most useful when participation is voluntary and organized around the person's goals. The WHO QualityRights initiative provides recovery-oriented, rights-based materials for peer support and advocacy.


Language, Identity, and Respectful Communication


Person-first wording, such as person living with schizophrenia, often helps maintain focus on the individual. Some people prefer person with schizophrenia, and others use identity-first terminology or a different self-description. The reliable practice is to use the individual's preferred language, avoid demeaning labels, and preserve diagnostic specificity when it matters medically.


Terms such as schizophrenic used as a casual insult, psycho used to imply dangerousness, or crazy used to discredit someone's account often compress a complex experience into ridicule. Writers should also avoid describing a person as a victim of schizophrenia as a default identity, calling someone noncompliant without explaining barriers or preferences, or treating hospital admission as proof that future autonomy is impossible.


In clinical writing, hallucination, delusion, psychotic symptom, schizophrenia, disability, clinical risk, and confirmed diagnosis should be used according to their actual meanings. A person reporting an unusual experience is not thereby diagnosed. Similarly, criticizing stigma does not require minimizing genuine distress or the need for specialist help.


Small choices in everyday conversation matter. Instead of saying, "Someone like you could never handle this," ask what support would make the task workable. Instead of calling a colleague "unstable" because their psychiatric history is known, describe the specific behavior or requirement that is relevant. Instead of announcing another person's diagnosis, ask what information they want shared.


Disclosure and Privacy: Who Should Know?


A person can choose to disclose a diagnosis to some people and keep it private from others, subject to specific legal or safety duties that vary by setting. Disclosure may help someone request adjustments, seek understanding, or form closer support relationships. It can also expose them to prejudice. There is no universally correct disclosure strategy.


A practical decision involves the purpose of disclosure, the recipient's trustworthiness, how much information is necessary, the available privacy protections, and what the person wants to happen next. Some situations call only for describing a functional need, such as predictable work hours, without sharing a full diagnosis. Specific workplace and accommodation rights depend on jurisdiction; questions about individual legal protections should be reviewed with a qualified local adviser or appropriate rights organization.


When someone tells you they have schizophrenia, do not treat their disclosure as an invitation to tell other people. Ask what they want you to understand, whether there are helpful adjustments, and what confidentiality boundaries they prefer. A diagnosis shared in confidence should not become casual social information.


How Families, Friends, and Partners Can Reduce Stigma


A supportive relationship makes room for both clinical realities and the person's ordinary interests. Talk about studies, work, food, recreation, projects, and daily events alongside health questions. Ask whether help is wanted before taking over a decision. Where support is requested, focus on concrete matters such as getting to an appointment, finding accessible services, organizing documents, or planning what to do if symptoms intensify.


If someone describes a distressing belief or perceptual experience, acknowledge their emotional experience without endorsing a belief you cannot verify. Responding, "That sounds frightening; how can I help you feel safer?" preserves connection. Repeated arguments about the factual content of an active delusion may heighten distress. An appropriate clinical team can help develop a person-specific communication and safety plan. NIMH guidance for families.


Supporters should also maintain healthy boundaries and access their own education or assistance. Respectful boundaries can coexist with compassion: neither person benefits when every conflict is attributed to schizophrenia or when serious safety concerns are ignored. Family psychoeducation is most effective when collaboration, consent, and respect are explicit. NICE.


What Employers, Educators, Journalists, and Clinicians Can Do


Employers and schools


Establish clear expectations and evaluate individual performance. Train managers to respond consistently to disclosure and privacy requests. Offer reasonable, relevant accommodations where required or feasible, without making assumptions about incapacity. Create confidential channels for discrimination complaints, and consult specialized supported employment or education services when the person wishes to use them.


Journalists, editors, and content creators


Do not make a psychiatric diagnosis a sensational headline unless it is verified, relevant, and ethically publishable. Avoid stock imagery and language that makes everyone with schizophrenia appear dangerous, incapacitated, or permanently distressed. Include credible clinical information and perspectives from people with lived experience, without suggesting that one person's story represents the entire population.


Where reporting addresses violence or crisis, distinguish confirmed facts about the incident from broader unsupported claims about psychiatric diagnoses. Discuss protective factors, treatment access, victimization, and recovery when relevant. These editorial principles align with the Lancet Commission emphasis on lived experience and structural discrimination.


Health professionals and service leaders


Assess the immediate concern on its merits, including physical health complaints, medication effects, trauma exposure, and accessibility needs. Offer shared decision-making, ensure interpretation and culturally responsive communication, and keep care plans centered on the person's goals. Review unequal access to psychological interventions, follow-up care, physical health examinations, and social supports. Anti-stigma education should be evaluated through measurable behavior and equity outcomes, not simply attendance at a training event.


The 2025 health care stigma systematic review and WHO and OHCHR guidance give practical reasons to address institutional processes as well as personal attitudes.


Which Anti-Stigma Interventions Have Evidence?


Social contact and education


Social contact interventions bring members of the public, students, professionals, or other audiences into meaningful contact with people who have lived experience of mental illness. They can involve in-person conversation, co-produced activities, or facilitated narratives. Direct or mediated contact combined with accurate education can change attitudes and reduce social distance, although outcomes vary by context and the duration of observed effects.


A 2026 updated meta-analysis of contact interventions synthesized more than 200 reports and found reductions in public mental-health stigma across immediate and shorter-term follow-up assessments, with variation across intervention formats and participants. This is evidence for contact-based stigma reduction across mental-health conditions; every effect should not be assumed to be specific to schizophrenia or durable over years. Participation and storytelling should be voluntary, fairly supported, and directed by people with lived experience.


Psychological programs for internalized stigma


Psychoeducation, cognitive approaches, skills-based components, and peer-oriented elements may improve aspects of self-stigma. Evidence is stronger for some measured attitudes and self-stigma scores than for every downstream employment, housing, or health outcome. The Lamarca and colleagues review supports multicomponent approaches while leaving questions about long-term effectiveness, access, and the best fit for particular individuals.


Rights-based systems and participation


Anti-discrimination laws, transparent complaints processes, inclusive employment practice, equitable physical health services, housing support, and community-based care target structures rather than perceptions alone. The WHO and OHCHR 2023 guidance calls for human-rights-based legal frameworks and person-centered community services. These proposals are normative and policy guidance; they should be evaluated alongside local implementation results rather than presented as randomized clinical treatment effects.


The broad Lancet Commission treats meaningful inclusion of people with lived experience as foundational to reform. A sustainable strategy allows those directly affected to help set goals, design measures, and judge whether changes improve real opportunities and treatment.


Schizophrenia, Recovery, and Social Inclusion


Recovery-oriented care recognizes that individual goals differ. One person may prioritize relief from frightening voices, another may want to resume college, a third may value reliable housing, and another may focus on relationships or a meaningful routine. Clinical treatment and social support should be planned around those goals and reviewed over time.


Evidence-based care can include clinician-prescribed antipsychotic medication with appropriate monitoring, cognitive behavioral therapy for psychosis, family education, support for work or education, cognitive remediation where indicated, peer support, and physical-health services. Medication can cause significant adverse effects, including metabolic and movement-related problems, so an individualized discussion of expected benefits, risks, and alternatives is part of responsible care. NIMH and NICE CG178 describe these components.


Coordinated specialty care after a first psychotic episode integrates multiple services, including educational and employment assistance, to support recovery and reduce disruption. The NIMH RAISE research program found improvements in engagement, symptoms, relationships, and quality of life compared with usual care. This evidence addresses early psychosis services and must not be generalized as a uniform outcome for all stages or diagnoses.


Combating stigma is part of recovery because belonging, opportunity, respect, and material circumstances influence the life a person can build. Removing discriminatory barriers does not itself treat every clinical symptom, and clinical treatment alone cannot correct discriminatory institutions. Both pathways matter to individual functioning and quality of life.



When Clinical Assessment or Urgent Help Matters


A discussion of stigma should never prevent timely assessment of concerning symptoms. If someone experiences persistent hallucinations, fixed beliefs that substantially disrupt life, severe confusion, pronounced behavioral change, or a rapid decline in functioning, a qualified health professional should assess the situation. Acute confusion, fever, neurological symptoms, medication toxicity, or new symptoms following substance exposure may need prompt medical evaluation because psychosis can arise from causes other than schizophrenia. NIMH Understanding Psychosis.


Immediate emergency assessment is warranted when a person is at imminent risk of self-harm or harm to others, is unable to meet basic survival needs, has severe acute confusion, or shows possible catatonia with immobility, refusal of fluids, or other dangerous physical signs. These are assessments of actual circumstances, not assumptions based on a diagnosis. In the United States, call 911 for life-threatening emergencies; for suicidal or emotional crisis support, call or text 988. Elsewhere, use local emergency and crisis services. NIMH.


Frequently Asked Questions


Is schizophrenia stigma still common?


Yes. The WHO reports that stigma, discrimination, and human-rights violations remain common. Their forms and severity differ by society, institution, and individual circumstances. Research shows that even trained health professionals can hold or act on stigmatizing assumptions.


Why is schizophrenia more stigmatized than many other diagnoses?


Public beliefs about unpredictability, dangerousness, chronic disability, and unfamiliar experiences can amplify fear and social distance. Historic institutionalization, unequal treatment, sensational media coverage, and limited contact with people living ordinary lives with schizophrenia contribute to these attitudes. These factors interact, and their relative contribution varies across communities. The Lancet Commission reviews stigma as a multilevel social problem.


Does the term schizophrenic always offend people?


Preferences vary. For general editorial and clinical communication, person with schizophrenia is usually a respectful default, but asking the individual is better than assuming everyone uses the same description. Avoid using psychiatric language as an insult or metaphor for inconsistency.


Is self-stigma a symptom of schizophrenia?


Self-stigma is a response to negative stereotypes and social contexts that can affect people with many diagnoses. It is not a schizophrenia diagnostic criterion. Researchers measure it separately from hallucinations, delusions, negative symptoms, and cognitive impairment. Self-stigma systematic review.


Can a person with schizophrenia have a fulfilling life?


Yes. Individual outcomes and support needs vary, but recovery, relationships, meaningful work, education, community participation, and personal goals remain possible. Accessible treatment and social opportunity can help. Neither a diagnosis nor a group average predicts one person's trajectory. WHO.


Should I tell a friend, partner, or employer about my diagnosis?


Disclosure is a personal, context-dependent decision. Consider what you want to accomplish, who needs the information, what privacy protections apply, and how the person is likely to respond. You may wish to discuss options with a trusted clinician, peer supporter, advocate, or employment adviser. A full diagnostic history may not be necessary to describe a practical accommodation need.


What should I say when someone reveals a schizophrenia diagnosis?


Thank them for trusting you, listen without interrogation, respect confidentiality, and ask what kind of support they prefer. You can learn about the condition from authoritative sources without making assumptions about this person's individual experiences or goals. If someone reports immediate danger or urgent medical symptoms, respond to the actual risk and seek appropriate help.


Does educating people about schizophrenia eliminate discrimination?


Knowledge is useful, but information alone cannot remove every stereotype or systemic barrier. Contact-based interventions can reduce some attitudes and social distance, while access to fair employment, housing, health care, and legal protection requires policy and institutional change. Evidence should be evaluated separately for short-term attitude changes and sustained real-world equality. Lancet Commission.


Conclusion


Schizophrenia stigma is expressed through public myths, interpersonal rejection, internalized shame, and institutional discrimination. Accurate understanding begins by distinguishing the diagnosis from the individual and separating schizophrenia from the wider clinical phenomenon of psychosis. A constructive response protects privacy and autonomy, supports accessible evidence-based care, and removes barriers to housing, relationships, employment, education, and full participation in community life.


Research supports multicomponent approaches that combine meaningful contact, recovery-oriented support, professional accountability, and rights-based institutional change. The goal is a society in which people living with schizophrenia can obtain appropriate treatment and pursue valued lives on their own terms.


Related Articles







References


Individual Placement and Support research overview (2024). Individual placement and support: History, current status, and future directions. Psychiatry and Clinical Neurosciences Reports. DOI: 10.1002/pcn5.122.


Lamarca, M., et al. (2024). Reducing self-stigma in psychosis: A systematic review and meta-analysis of psychological interventions. Psychiatry Research, 342, 116262. DOI: 10.1016/j.psychres.2024.116262.


National Institute for Health and Care Excellence. (2014; last reviewed 2025). Psychosis and schizophrenia in adults: prevention and management, CG178. NICE.


National Institute of Mental Health. (2024). Schizophrenia. U.S. National Institutes of Health.


National Institute of Mental Health. (n.d.). Understanding Psychosis. U.S. National Institutes of Health.


National Institute of Mental Health. (n.d.). Recovery After an Initial Schizophrenia Episode (RAISE). U.S. National Institutes of Health.


Sarraf, L., Lepage, M., & Sauvé, G. (2022). The clinical and psychosocial correlates of self-stigma among people with schizophrenia spectrum disorders across cultures: A systematic review and meta-analysis. Schizophrenia Research, 248, 64–78. DOI: 10.1016/j.schres.2022.08.001.


Schizophrenia spectrum stigma in healthcare: a systematic review. (2025). Primary peer-reviewed review record. Frontiers in Psychiatry. DOI: 10.3389/fpsyt.2025.1648957.


Self-stigma in schizophrenia: a systematic review and meta-analysis of 37 studies from 25 high- and low-to-middle-income countries. (2023). Primary peer-reviewed review record. PubMed.



Thornicroft, G., et al. (2022). The Lancet Commission on ending stigma and discrimination in mental health. The Lancet, 400, 1438–1480. DOI: 10.1016/S0140-6736(22)01470-2.



World Health Organization. (2023). Mental health: Promoting and protecting human rights. WHO.


World Health Organization. (2026, September 11). Schizophrenia. WHO.


World Health Organization & Office of the United Nations High Commissioner for Human Rights. (2023). Mental health, human rights and legislation: guidance and practice. WHO.

 
 
bottom of page